Embracing risk key to economic revival
A strong economy requires risk-takers, and it is the bold and brash who will seize opportunities as the economy rebounds.
A strong economy requires risk-takers, and it is the bold and brash who will seize opportunities as the economy rebounds.
Call it a trickle-down effect, but not the kind President Reagan would have liked. The recession has cost most institutional
investors, such as university endowments, about a quarter of their value. As a result, venture capitalists’ primary source
of funding has dried up. The implications for Hoosier entrepreneurship are stark.
INVESTING Growing government likely to keep bull at bay I want to make a new friend in Washington. I would like to believe the Environmental Protection Agency can be that friend. All I need to do is get the folks there to like me, then convince them it’s the economic environment they need to protect […]
Embracing risk key to revival Executives shouldn’t become timid Risk has a bad name these days, for understandable reasons. In recent years, many corporate executives managed as if the boom times never would end, along the way ratcheting up debt to unfathomable levels. Many bankers, meanwhile, doled out loans to the lowliest of borrowers, and […]
The recession’s domino effect Call it a trickle-down effect, but not the kind President Reagan would have liked. The recession has cost most institutional investors, such as university endowments, about a quarter of their value. As a result, venture capitalists’ primary source of funding has dried up. The implications for Hoosier entrepreneurship are stark. “Right […]
Call it a trickle-down effect, but not the kind President Reagan would have liked. The recession has cost most institutional investors, such as university endowments, about a quarter of their value. As a result, venture capitalists’ primary source of funding has dried up. The implications for Hoosier entrepreneurship are stark. “Right now, it is very […]
Risk has a bad name these days, for understandable reasons. In recent years, many corporate executives managed as if the boom times never would end, along the way ratcheting up debt to unfathomable levels. Many bankers, meanwhile, doled out loans to the lowliest of borrowers, and traded complex securities few truly understood. Yet a strong […]
Normal 0 false false false MicrosoftInternetExplorer4 Several Indianapolis businesses are taking steps to protect against the spread of swine flu as the number of confirmed cases in the United States continues to rise. The U.S. Centers for Disease Control and Prevention yesterday reported 403 confirmed cases across 36 states – 124 more than were […]
Several Indianapolis businesses are taking steps to protect against the spread of swine flu as the number of confirmed cases in the United States continues to rise. The U.S. Centers for Disease Control and Prevention yesterday reported 403 confirmed cases across 36 states – 124 more than were confirmed the day before. Worldwide, the number […]
The struggling stock market took its toll on Lilly Endowment in 2008, dropping the value of its assets by 26 percent, from $7.7 billion to $5.7 billion, it announced today. The Indianapolis-based endowment’s value hit its lowest level in more than 10 years. The most recent peak was $15.5 billion in 2000. The drop means […]
The struggling stock market took its toll on Lilly Endowment in 2008, dropping the value of its assets by 26 percent, from $7.7 billion to $5.7 billion, it announced today. The Indianapolis-based endowment’s value hit its lowest level in more than 10 years. The most recent peak was $15.5 billion in 2000. The drop means […]
A prediction by a military historian in a recent issue of Foreign Policy has something for everyone, including
people interested in companies right here in Indiana.
Writing in a special section about the future, Martin van Creveld notes that…
Compared with some of his pharmaceutical CEO peers these days, John Lechleiter has his company on a diet. Instead of using a mega-merger to bulk up before the famine that patent expirations will bring on the industry next year,
Lechleiter has Eli Lilly and Co. burning management fat while looking for smaller companies to munch on.
HEALTH CARE Pharma sets sail to China Drug companies-including Indianapolis-based Eli Lilly and Co.-are looking to ramp up sales internationally as the U.S. market contracts for the first time in 50 years. Sales of pharmaceuticals will fall 1 percent to 2 percent in the United States this year, according to a revised forecast from Connecticut-based […]
Compared with some of his pharmaceutical CEO peers these days, John Lechleiter has his company on a diet. Instead of using a mega-merger to bulk up before the famine that patent expirations will bring on the industry next year, Lechleiter has Eli Lilly and Co. burning management fat while looking for smaller companies to munch […]
While military contractors scramble to protect big projects from Defense Secretary Robert Gates’ budgetary ax, Indianapolis
engine-maker Rolls-Royce is sitting pretty.
Analyst: Expect prasugrel OK by May Eli Lilly and Co. should win regulatory approval for its blood-thinner prasugrel by the end of the month, according to one Wall Street analyst. Dr. Tim Anderson, an analyst at Sanford C. Bernstein & Co., made the prediction in a note to investors April 21. He added that Wall […]
While military contractors scramble to protect big projects from Defense Secretary Robert Gates’ budgetary ax, Indianapolis engine-maker Rolls-Royce is sitting pretty. Rolls-Royce, which employs 4,300 in Indianapolis, is developing a key component for the Marine Corps’ version of the F-35 Joint Strike Fighter, potentially a big winner under a sweeping overhaul of priorities Gates unveiled […]
A federal judge in Indianapolis blocked today’s planned launch of a generic version of Evista, an osteoporosis and breast cancer drug made by Indianapolis-based Eli Lilly and Co. Sarah Evans Barker granted Lilly a preliminary injunction against Israel-based Teva Pharmaceuticals Industries Ltd. In March, Teva said it would wait until April 23 to launch its […]
Eli Lilly and Co. should win regulatory approval for its blood-thinner prasugrel by the end of the month, according to one Wall Street analyst. Dr. Tim Anderson, an analyst at Sanford C. Bernstein & Co., made the prediction in a note to investors on Tuesday. He added that Wall Street expects prasugrel to receive full approval, despite being dogged […]